Turn Therapeutics’ shares surged 134% in after-hours trading following its Nasdaq debut, despite a sharp decline during the regular session.
Turn Therapeutics’ shares surged 134% in after-hours trading following its Nasdaq debut, despite a sharp decline during the regular session.